A Study of mRNA-3745 in Participants With Glycogen Storage Disease Type 1a (GSD1a)

Status:
Not yet recruiting

Trial end date:
2024-01-19

Target enrollment:

Participant gender:

The main goal of this trial is to evaluate the safety and tolerability of mRNA-3745 via intravenous (IV) administration in participants with GSD1a.

Phase 1

ModernaTX, Inc.